Can glucose-lowering drugs impact mortality in COVID-19 patients with type 2 diabetes?

CAMBRIDGE, MA – October 27, 2020— In a preprint paper, “Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19,” researchers conclude a neutral effect on mortality and other adverse outcomes. Though, given the close relationship between diabetes and COVID-19, they call for more prospective studies.…